News

Deal Announcements

Carbylan Closes $20 Million Second Round

Tuesday, November 27, 2007 5:30:00 AM PDT | VentureDeal Staff
PALO ALTO, CA -- Medical device company Carbylan BioSurgery, Inc. said that it has secured $20 million in new investment from a syndicate of venture capital firms.

Carbylan develops bioresponsive medical products that enhance healing, provide better surgical outcomes and hope to improve the quality of patient life.  The company has several lead product candidates such as chemically engineered polymers of hylauronic acid.

Investors in the round included Vivo Ventures, Alta Partners and InterWest Partners.  The company said it will use the proceeds to advance its lead candidates through clinical trials.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1